Polskie Radio looks at a newer weight loss drug being framed as a successor to Ozempic. The material is thin, so tap through for which drug it is.
Recap by typeshit. Full story at www.polskieradio.pl.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Sara Ashley O'Brien reports on a growing number of teen boys using peptides, supplements and online advice to change how they look and feel.
Polish public radio covers a new weight-loss medication being talked about as a successor to Ozempic. Details are thin beyond the headline.
Loading…